316 filings
Page 11 of 16
CORRESP
49ji 5xl90ssl5q
2 Nov 17
Correspondence with SEC
12:00am
D
9ap2cg
11 Oct 17
$23.44M in equity / options / securities to be acquired, sold $23.44M, 11 investors
12:00am
8-K
dqeshmbu3j1p9kix ew
27 Sep 17
Bellerophon Announces $23 Million Private Placement
12:00am
8-K/A
1ra2enkc
15 Sep 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
n2o21 ptimr5n3
14 Sep 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
idimi65 o5s1kugt4y4
5 Sep 17
Regulation FD Disclosure
12:00am
8-K
znqofgk9 1zk509aa6nn
7 Aug 17
Bellerophon Reports Second Quarter 2017 Financial Results
12:00am
8-K
m2lk xu63b7zfte
3 Aug 17
Company to Host Key Opinion Leader Event on PH-ILD in New York City
12:00am
S-8
k511 w0dd
21 Jul 17
Registration of securities for employees
12:00am
8-K
byql5dhmwqqto1 m9s2m
22 May 17
Positive Clinical Data on INOpulse® Presented at the American Thoracic Society 113th International Conference
12:00am
D
m0qqiq3ztepcurauqd
19 May 17
$1.61M in options, sold $1.61M, 7 investors
12:00am
8-K
wxwseldfv 1qj
15 May 17
Bellerophon Reports First Quarter 2017 Financial Results
12:00am
8-K
va83k3stjn
12 May 17
Bellerophon Announces $3.0 Million Registered Direct Offering
12:00am
424B5
amf65jw77 hmhlnt5w
11 May 17
Prospectus supplement for primary offering
12:00am
8-K
l25c6cgxboqz6
5 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
zmnrxo
2 May 17
Termination of a Material Definitive Agreement
12:00am
8-K
2mdlu7
1 May 17
Bellerophon to Present Positive Clinical Data on INOpulse® at the American Thoracic Society 113th International Conference
12:00am